论文部分内容阅读
目的了解血液透析患者肝炎病毒感染现况,为控制肝炎病毒的医源性感染提供依据。方法对正在大连市6家医院进行血液透析治疗的223例血液透析患者和内科非血液透析患者200例进行乙肝病毒血清标志物(二对半、抗-HCV、抗-HGV)检测。结果223例血液透析患者中HBV感染率为78.0%,抗-HCV阳性检出率为35.0%,抗-HGV阳性检出率为4.9%;均显著高于非血液透析患者。结论血液透析是血液传播病毒性肝炎发生主要原因之一。
Objective To understand the status of hepatitis virus infection in hemodialysis patients and provide basis for controlling iatrogenic infection of hepatitis virus. Methods Hepatitis B virus serum markers (two-and-a-half, anti-HCV and anti-HGV) were detected in 223 hemodialysis patients and 200 non-hemodialysis patients undergoing hemodialysis in 6 hospitals in Dalian. Results 223 cases of hemodialysis patients with HBV infection was 78.0%, anti-HCV positive rate was 35.0%, anti -HGV positive rate was 4.9%; were significantly higher than non-hemodialysis patients. Conclusion Hemodialysis is one of the main causes of blood-borne viral hepatitis.